or
forgot password
  • cancer clinical trials in san francisco, CA

  • S0820, Adenoma and Second Primary Prevention Trial
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    Kaiser Permanente-San Francisco
    Colorectal Neoplasms
    Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
    University of California at San Francisco
    San Francisco, California 94115
    Multiple Myeloma, Non-Hodgkin Lymphoma, Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer, Ewing's Osteosarcoma, Chronic Lymphocytic Leukemia
    Fear of Recurrence Pilot Intervention for Women With Breast Cancer
    University of California, San Francisco
    San Francisco, California 94143
    Cancer Recurrence
    Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer
    California Pacific Medical Center
    San Francisco, California 94115
    Pancreaticobiliary Cancers, Jaundice, Bile Duct Obstruction
    Phase I Biomarker Study (BMS-936558)
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Renal Cell Carcinoma
    Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
    Northern Californai Melanoma Center, St. Mary's Medical Center
    San Francisco, California 94117
    Malignant Melanoma, Metastatic
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women
    SFSU Student Health Center
    San Francisco, California 94132
    Human Papillomavirus, CIN 2, CIN 3
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Prostate Cancer
    Development and Pilot Test of an Elective Bilateral Salpingo-Oophorectomy (BSO) Decision Support Guide
    UCSF
    San Francisco, California 941430324
    Surgical Procedure, Unspecified
    131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
    University of California, San Francisco
    San Francisco, California 94143
    Neuroblastoma
    Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Bacterial Infection, Leukemia, Musculoskeletal Complications, Neutropenia
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids
    University of California, San Francisco
    San Francisco, California 94143
    Uterine Fibroids
    Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
    UCSF
    San Francisco, California 941430324
    Pheochromocytoma, Paraganglioma
    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
    University of California San Francisco
    San Francisco, California 941104206
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Pancreatic Cancer, Adenocarcinoma, Pancreatic Neoplasms
    Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer, Fertility
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Kaiser Permanente Medical Center - San Francisco Geary Campus

    Trial Locations
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    California Pacific Medical Center - California Campus
    Arthralgia, Breast Cancer, Pain
    Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
    University of California San Francisco
    San Francisco, California 941104206
    Brain Cancer, MALIGNANT GLIOMA, Glioblastoma, Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Anaplastic Oligo-astrocytoma (AOA), Anaplastic Mixed Gliomas, Malignant Glioma NOS
    Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    B-cell Childhood Acute Lymphoblastic Leukemia, Peripheral T-cell Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute Lymphoblastic Leukemia
    A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
    Investigational Site Number 840012
    San Francisco, California 94143
    Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Tumors, Medical Oncology, Neoplasms
    Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
    Investigational Site Number 840005
    San Francisco, California 94117
    Hematopoietic Neoplasm
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    University of California San Francisco UCSF (SC)
    San Francisco, California
    Advanced Solid Tumors, Excluding Breast Cancer
    Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide
    University of California San Francisco
    San Francisco, California 941104206
    Myeloma
    Radiation Therapy in Treating Patients With Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction
    A Study of Axitinib in Advanced Carcinoid Tumors
    University of California San Francisco (UCSF)
    San Francisco, California 94115
    Carcinoid Tumor
    Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
    Investigational Site Number 840012
    San Francisco, California 94143
    Hematopoietic Neoplasm
    Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer
    Interleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell Cancer
    University of California San Francisco Medical Center
    San Francisco, California 94143
    Recurrent Neuroendocrine Carcinoma of the Skin, Stage I Neuroendocrine Carcinoma of the Skin, Stage II Neuroendocrine Carcinoma of the Skin, Stage III Neuroendocrine Carcinoma of the Skin, Stage IV Neuroendocrine Carcinoma of the Skin
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 58906
    San Francisco, California 94115
    Heavy Uterine Bleeding, Uterine Fibroids
    Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide
    UCSF Center for Reproductive Health
    San Francisco, California 94115
    Low Grade Glioma
    Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
    California Pacific Medical Center
    San Francisco, California 94115
    Stage IV Pancreatic Cancer
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    UCSF Medical Center
    San Francisco, California 94121
    Multiple Myeloma
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    California Pacific Medical Center
    San Francisco, California 94115
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Breast Cancer, Breast Neoplasm
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    University of California - San Francisco
    San Francisco, California 94143
    Ulcerative Colitis
    A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
    UCSF-Helen Diller Family Comprehensive Cancer Care Center
    San Francisco, California 94115
    Relapsed or Refractory Solid Tumors
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    University of California, San Francisco (UCSF), Hellen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    HER2 Negative Breast Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of California, San Francisco
    San Francisco, California 94143
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Colorectal Cancer Metastatic
    A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
    UCSF School of Medicine
    San Francisco, California 94143-0106
    Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia
    EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
    Investigational Site Number 840005
    San Francisco, California 94117
    Ovarian Cancer Recurrent
    Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer
    Integrative Approaches for Cancer Survivorship
    University of California, San Francisco, Osher Center for Integrative Medicine
    San Francisco, California 94115
    Breast Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    University of California San Francisco
    San Francisco, California 941104206
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
    University of California, San Francisco Medical Center
    San Francisco, California 94115
    Breast Cancer
    Trial of pIL-12 Electroporation Malignant Melanoma
    UCSF Helen Diller Comprehensive Cancer Center
    San Francisco, California 94143
    Melanoma
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    CPMCRI / Pacific Hematology Oncology Associates
    San Francisco, California 94115
    Metastatic Colorectal Cancer, Colorectal Cancer
    BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
    University of California, San Francisco
    San Francisco, California 94143
    BRAF Mutant Metastatic Melanoma
    Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
    UCSF Helen Diller Family Comprehensive Cancer Center

    Trial Locations
    UCSF Helen Diller Family Comprehensive Cancer Center
    Kaiser Permanente-San Francisco
    Colorectal Cancer
    Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
    University of California, San Francisco (UCSF)
    San Francisco, California 94115
    Metastatic Breast Cancer
    Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
    University of California, San Francisco
    San Francisco, California 94143
    Epithelial Ovarian Cancer
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Kaiser Permanente-San Francisco
    San Francisco, California 94115
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
    University of California San Francisco
    San Francisco, California 941104206
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
    UCSF
    San Francisco, California 941430324
    Advanced, Incurable Solid Tumors
    Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Diffuse Astrocytoma, Recurrent Childhood Fibrillary Astrocytoma, Recurrent Childhood Gemistocytic Astrocytoma, Recurrent Childhood Giant Cell Glioblastoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Gliomatosis Cerebri, Recurrent Childhood Gliosarcoma, Recurrent Childhood Oligoastrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Pineoblastoma, Recurrent Childhood Pleomorphic Xanthoastrocytoma, Recurrent Childhood Protoplasmic Astrocytoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    University of California San Francisco Medical Center-Mount Zion
    San Francisco, California 94115
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma
    University of California, San Francisco
    San Francisco, California 94143
    Recurrent/Refractory CNS, Intraocular Lymphoma
    Phase I Tolerability, Efficacy, and Safety Study of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Metastatic Solid Tumors